Viral pneumonias

  title={Viral pneumonias},
  author={Jason W Chien and John L. Johnson},
  journal={Postgraduate Medicine},
  pages={41 - 52}
PREVIEW Viral pneumonias resulting from community outbreaks of influenza, respiratory syncytial virus infection, and parainfluenza can be life-threatening in elderly and immunocompromised persons. In this article, Drs Chien and Johnson discuss the clinical characteristics of these viruses, therapeutic options, and preventive measures. Part 1 of this article, in the January issue, presented a multifaceted approach to diagnosis of viral pneumonias. Part 2, published in February, focused on the… 
Clinical manifestations of parainfluenza infection in children.
The identification of parainfluenza virus in illnesses classically considered to be due to other viruses is intriguing and may have important implications in the management of childhood illness clinically.
Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population.
Exposure histories and molecular analysis of HPIV3 isolates suggested that both community acquired and nosocomially transmitted infections occurred during this outbreak.
Imaging of pulmonary viral pneumonia.
Although the radiologic manifestations of viral pneumonia are nonspecific and difficult to differentiate from those of other infections, it is important to consider viral infection when confronted with a rapidly progressive pneumonia in patients with risk factors for infection.
A Series of Five Adult Cases of Respiratory Syncytial Virus-Related Acute Respiratory Distress Syndrome
Five cases of respiratory syncytial virus infection of the lower respiratory tract in immunocompromised adults suffering from severe respiratory insufficiency leading to bilateral pneumonia and fulfilling the criteria for acute respiratory distress syndrome are presented.
Severe community-acquired pneumonia.
Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy
A number of recent studies and guidelines addressing issues related to early clinical suspicion and prompt empiric antimicrobial therapies are published and will be reviewed in this article.
Optimizing Treatment Outcomes in Severe Community-Acquired Pneumonia
The assessment of severity of CAP helps physicians to identify patients who could be managed safely in an ambulatory setting and may also play a crucial role in decisions about length of hospital stay and time of switching to oral antimicrobial therapy in different groups at risk.
Antimicrobial Treatment of Community-Acquired Pneumonia
Atypical Pneumonia: Definition, Causes, and Imaging Features.
Clarifying and unifying the definition of atypical pneumonia among the medical community, including radiologists, are of extreme importance because the prompt diagnosis and prevention of community spread of some atypicals microorganisms can have a relevant impact on local, regional, and global health policies.


Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults.
RSV should be considered in the differential diagnosis for adults hospitalized between November and April with community-acquired lower respiratory infection, with serologic evidence of RSV infection making RSV one of the four most common pathogens identified.
Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
Since infection with RSV and PIV can be severe and life-threatening and treatment with ribavirin is relatively benign, it seems warranted to treat immunocompromised patients infected withRSV or PIV with ribvirin until otherwise proven unwarranted.
An outbreak of respiratory syncytial virus in a bone marrow transplant center.
An outbreak of respiratory syncytial virus infection occurred among 31 patients in a marrow transplant center over a 13-week period beginning in January 1990, and 14 patients with pneumonia, 14 (78%) died.
Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases.
The intent of the new recommendation is to allow practitioners to decide whether ribavirin therapy is appropriate or not by taking into account the particular clinical situation and their own preferences.
Respiratory Syncytial Virus Immune Globulin Intravenous
Clinical data show RSV—IGIV is an effective prophylactic agent against serious RSV disease in select groups of infants and children.
From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses.
  • C. Heilman
  • Medicine
    The Journal of infectious diseases
  • 1990
A Workshop on Respiratory Syncytial and Parainfluenza Viruses was held on 4 and 5 May 1987 to assess the current status and future direction of research efforts on these two virus groups.
Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants.
  • Medicine
  • 1998
Objective. To determine the safety and efficacy of prophylaxis with palivizumab in reducing the incidence of hospitalization because of respiratory syncytial virus (RSV) infection in high-risk
Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV
Recommendations for its use are based on a large, randomized study demonstrating a 55% reduction in the risk of hospitalization attributable to respiratory syncytial virus (RSV) infections in high-risk pediatric patients, and discontinuation of injections for adverse events related to palivizumab was rare.
Evaluation of Four Methods for the Diagnosis of Respiratory Syncytial Virus Infection in Older Adults
Four methods of rapid diagnosis of respiratory syncytial virus (RSV) infection in older adults and to compare sensitivities with serologic analysis are evaluated.
"Childhood" viruses as a cause of pneumonia in adults.
Adults who work around children, who are frequently exposed to other adults and children with respiratory tract infections, or who are military recruits appear to be at risk of infection or reinfection with one of these agents.